Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$956M |
| 2 |
Apple
AAPL
|
+$935M |
| 3 |
Warner Bros
WBD
|
+$783M |
| 4 |
Home Depot
HD
|
+$626M |
| 5 |
Amazon
AMZN
|
+$476M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$734M |
| 2 |
CERN
Cerner Corp
CERN
|
+$600M |
| 3 |
Marathon Petroleum
MPC
|
+$180M |
| 4 |
PBCT
People's United Financial Inc
PBCT
|
+$169M |
| 5 |
S&P Global
SPGI
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.95% |
| 2 | Healthcare | 14.76% |
| 3 | Financials | 13.17% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
LeMaitre Vascular
LMAT
$1.88B
| $17.6M | ﹤0.01% |
385,335
+33,900
| +10% | +$1.52M |
|
1852
LivePerson
LPSN
$35.3M
| $17.5M | ﹤0.01% |
82,651
+8,118
| +11% | +$2.28M |
|
|
IRBT
1853
DELISTED
iRobot
IRBT
| $17.5M | ﹤0.01% |
476,905
-8,572
| -2% | -$414K |
|
|
FRG
1854
DELISTED
Franchise Group, Inc.
FRG
| $17.5M | ﹤0.01% |
499,696
-14,759
| -3% | -$570K |
|
1855
Standex International
SXI
$4.03B
| $17.5M | ﹤0.01% |
206,298
+566
| +0.3% | +$53K |
|
1856
Syndax Pharmaceuticals
SNDX
$1.76B
| $17.5M | ﹤0.01% |
907,856
+52,441
| +6% | +$874K |
|
|
RDFN
1857
DELISTED
Redfin
RDFN
| $17.4M | ﹤0.01% |
2,109,892
-61,300
| -3% | -$701K |
|
|
ATRI
1858
DELISTED
Atrion Corp
ATRI
| $17.4M | ﹤0.01% |
27,612
+2,013
| +8% | +$1.32M |
|
1859
German American Bancorp
GABC
$1.9B
| $17.3M | ﹤0.01% |
507,490
+40,194
| +9% | +$1.46M |
|
1860
MannKind Corp
MNKD
$1.23B
| $17.3M | ﹤0.01% |
4,551,176
+16,671
| +0.4% | +$61.2K |
|
1861
Regenxbio
RGNX
$708M
| $17.3M | ﹤0.01% |
699,768
+14,129
| +2% | +$353K |
|
1862
SSR Mining
SSRM
$6.5B
| $17.3M | ﹤0.01% |
1,033,398
+772,556
| +296% | +$15.9M |
|
1863
Veeco
VECO
$3.28B
| $17.2M | ﹤0.01% |
889,139
-30,031
| -3% | -$666K |
|
1864
Dillards
DDS
$9.18B
| $17.2M | ﹤0.01% |
78,171
-7,370
| -9% | -$2.13M |
|
1865
Prothena Corp
PRTA
$475M
| $17.1M | ﹤0.01% |
631,680
-20,295
| -3% | -$594K |
|
|
HSKA
1866
DELISTED
Heska Corp
HSKA
| $17.1M | ﹤0.01% |
181,289
-2,074
| -1% | -$224K |
|
|
AGNT
1867
AGNT Inc
AGNT
$727M
| $17.1M | ﹤0.01% |
1,453,423
+45,382
| +3% | +$656K |
|
|
RVNC
1868
DELISTED
Revance Therapeutics, Inc.
RVNC
| $17.1M | ﹤0.01% |
1,236,952
-99,239
| -7% | -$1.53M |
|
|
PTRA
1869
DELISTED
Proterra Inc. Common Stock
PTRA
| $17.1M | ﹤0.01% |
3,682,795
+1,926,081
| +110% | +$11.8M |
|
1870
Enovix
ENVX
$1.02B
| $17M | ﹤0.01% |
2,178,334
+1,094,271
| +101% | +$10.3M |
|
1871
Vaxcyte
PCVX
$8.97B
| $17M | ﹤0.01% |
779,695
+57,732
| +8% | +$1.34M |
|
|
CDMO
1872
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $16.9M | ﹤0.01% |
1,108,759
+7,974
| +0.7% | +$118K |
|
1873
Astec Industries
ASTE
$997M
| $16.9M | ﹤0.01% |
414,567
-6,277
| -1% | -$267K |
|
|
AVID
1874
DELISTED
Avid Technology Inc
AVID
| $16.9M | ﹤0.01% |
650,375
-5,438
| -0.8% | -$159K |
|
|
MGI
1875
DELISTED
MoneyGram International, Inc. New
MGI
| $16.8M | ﹤0.01% |
1,682,672
+42,746
| +3% | +$430K |
|
Similar funds
Geode Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Geode Capital Management held 5,106 positions worth $683B, down 15% from $801B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 4.3%. Geode Capital Management opened 131 new positions and exited 89, leaving the 5,106-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2022 buy was Aspen Technology Inc: 402,046 shares worth $74M.
- Geode Capital Management added most to Microsoft in Q2 2022, an estimated $956M increase.
- Geode Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $734M.
- Geode Capital Management fully exited Cerner Corp in Q2 2022, selling an estimated $600M.
- Geode Capital Management's ten largest holdings make up 23% of its $683B portfolio in Q2 2022.
- Geode Capital Management opened 131 new positions and closed 89 in Q2 2022.
- Geode Capital Management's portfolio value fell 15% quarter-over-quarter to $683B.
Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.